Is lipoprotein-associated phospholipase A2 correlated with cardiovascular risk in European women?
Among the serum markers of inflammation, the Lp-PLA 2 is correlated with the progression, extension, and severity of cardiovascular disease (CVD) as well as to a greater mortality risk after coronary heart attack [2] . [...]Lp-PLA 2 has been recommended as an inflammatory marker for CVD risk assessm...
Saved in:
Published in | Indian journal of medical research (New Delhi, India : 1994) Vol. 137; no. 6; pp. 832 - 833 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
New Delhi
Medknow Publications & Media Pvt. Ltd
01.12.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Among the serum markers of inflammation, the Lp-PLA 2 is correlated with the progression, extension, and severity of cardiovascular disease (CVD) as well as to a greater mortality risk after coronary heart attack [2] . [...]Lp-PLA 2 has been recommended as an inflammatory marker for CVD risk assessment in patients with moderate or high risk based on Framingham criteria [3] . Risk ratios for coronary heart disease and ischaemic strokes increased progressively for every increase of 1 SD in Lp-PLA 2 activity adjusted for confounding variables.The 2010 ACCF/AHA Guidelines for Assessment of Cardiovascular Risk in Asymptomatic Adults recommend Lp-PLA 2 as a reasonable inflammation serum marker for CVD risk assessment in intermediate-risk asymptomatic adults [7] . |
---|---|
ISSN: | 0971-5916 |